Aeon
Connecting Sign in

Every public trading filing, minutes after it lands, in plain words.

Get alerts

← Feed

DAWN

Day One Biopharmaceuticals, Inc.

Alert me on DAWN
0
Insider buys, 6 months
0
Congress trades, 6 months
0
Signals, 6 months

After each filing

4
Nov 19, 2025 Sale Merendino Lauren Insider
1 week
+11.9%S&P +2.6%
1 month
+9.9%S&P +3.0%
3 months
+39.1%S&P +3.3%
6 months
No result
Nov 19, 2025 Sale York Charles N II Insider
1 week
+11.9%S&P +2.6%
1 month
+9.9%S&P +3.0%
3 months
+39.1%S&P +3.3%
6 months
No result
Nov 19, 2025 Sale Dubow Adam Insider
1 week
+11.9%S&P +2.6%
1 month
+9.9%S&P +3.0%
3 months
+39.1%S&P +3.3%
6 months
No result
Nov 19, 2025 Sale Bender Jeremy Insider
1 week
+11.9%S&P +2.6%
1 month
+9.9%S&P +3.0%
3 months
+39.1%S&P +3.3%
6 months
No result

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for DAWN 20 held · newest first
Loading the filings.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal
No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters
No lobbying reports on file.